Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Publication Title,Pubmed Url,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId,Dataset View_id
PublicationView,CA217297,10.1186/s13256-022-03660-9,J Med Case Rep,36434709,Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report,https://pubmed.ncbi.nlm.nih.gov/36434709,2022,"Lung cancer, Case Report, Lymphadenopathy, Covid-19, Covid-19 Vaccine","Shreya Tripathy, Nathaniel Alvarez, Shubham Jaiswal, Ryan Williams, Munaf Al-Khadimi, Sarah Hackman, William Phillips, Supreet Kaur, Sherri Cervantez, William Kelly, Josephine Taverna","Background: Given the current climate of the pandemic, lung cancer patients are especially vulnerable to complications from severe acute respiratory syndrome coronavirus 2 infection. As a high-risk population group, these patients are strongly advised to receive coronavirus disease 2019 vaccination in accordance with Center for Disease Control and Prevention guidelines to minimize morbidity and mo(Read more on Pubmed)","Computed Tomography, Positron Emission Tomography",Lung Adenocarcinoma,Lung,Not Applicable,Open Access,36434709,af2c5413-a4ab-4753-aca1-de6b6118d8a0,syn52543485,36434709
